^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
06/02/2022
Excerpt:
Recurrent or Progressive Disease....Useful in certain circumstances...Pilocytic astrocytomas...Carboplatin + vincristine (category 2B)